PYXS ▲ +0.6% - Pyxis Oncology, Inc.
$PYXS - Pyxis Oncology to Present Micvotabart Pelidotin (MICVO) Phase 1 Monotherapy Data in Late-Breaking Oral Presentation and Two Poster Presentations at EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics
27-OCT-2026 08:45 AM ET
Share this post
More filings for $PYXS
PYXS - Pyxis Oncology, Inc. - SEC Filing Update (09-OCT-2026) | ThinkSabio - Stocks SimplifiedOct 9, 2026PYXS - Pyxis Oncology, Inc. - SEC Filing Update (05-OCT-2026) | ThinkSabio - Stocks SimplifiedOct 5, 2026PYXS - Pyxis Oncology, Inc. - SEC Filing Update (02-OCT-2026) | ThinkSabio - Stocks SimplifiedOct 2, 2026PYXS ▼ -9.3% - Pyxis Oncology, Inc.Sep 30, 2026PYXS ▼ -7.9% - Pyxis Oncology, Inc.Sep 29, 2026PYXS ▲ +2.8% - Pyxis Oncology, Inc.Sep 9, 2026
View full $PYXS filing history →💬 Comments
Loading comments…
Leave a comment